Cashu
Allergan Aesthetics Launches Innovative TrenibotE at AAD Meeting, Addressing Patient Aesthetic Concerns
4 days ago
Stocks
Health Care
abbv
Abbvie
NYSE: ABBV
-6.14 (-2.86%)
208.84
USD
At close at Apr 03, 20:33 UTC
Latest Abbvie News
prnewswire.com
Allergan Aesthetics Releases Findings on the Safety and Efficacy of Repeat TrenibotE Treatments and Data on Medical Weight Loss Aesthetics Patient Behaviors at the 2026 American Academy of Dermatology Meeting (AAD)
6 days ago
prnewswire.com
AbbVie to Highlight New Clinical and Real-World Evidence Advancing Standards of Care in Immune-Mediated Skin Diseases at the 2026 AAD Annual Meeting
9 days ago
prnewswire.com
Allergan Aesthetics Reinforces Scientific Differentiation and Leadership with 21 Evidence-Based E-Posters at the 2026 Aesthetic & Anti-Aging Medicine World Congress (AMWC)
10 days ago
prnewswire.com
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVDERM at AMWC Monaco
10 days ago
cnbc.com
Google partners with Agile Robots, growing its AI robotics footprint
12 days ago
prnewswire.com
AbbVie Named Official Pharmaceutical Partner of Major League Baseball
12 days ago
cnbc.com
Switzerland risks the ire of the White House as it flags potential currency intervention
17 days ago
benzinga.com
Johnson & Johnson-Protagonist Therapeutics Partnered New Psoriasis Pill Wins FDA Nod, Shakes Up Competition With AbbVie
17 days ago
prnewswire.com
Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
17 days ago
cnbc.com
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
18 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.